These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10964539)

  • 1. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons.
    Soulika AM; Khan MM; Hattori T; Bowen FW; Richardson BA; Hack CE; Sahu A; Edmunds LH; Lambris JD
    Clin Immunol; 2000 Sep; 96(3):212-21. PubMed ID: 10964539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested.
    Schmidt S; Haase G; Csomor E; Lütticken R; Peltroche-Llacsahuanga H
    J Biomed Mater Res A; 2003 Sep; 66(3):491-9. PubMed ID: 12918031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3.
    Soulika AM; Holland MC; Sfyroera G; Sahu A; Lambris JD
    Mol Immunol; 2006 May; 43(12):2023-9. PubMed ID: 16472861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
    Nilsson B; Larsson R; Hong J; Elgue G; Ekdahl KN; Sahu A; Lambris JD
    Blood; 1998 Sep; 92(5):1661-7. PubMed ID: 9716594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
    Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
    Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles.
    Furlong ST; Dutta AS; Coath MM; Gormley JJ; Hubbs SJ; Lloyd D; Mauger RC; Strimpler AM; Sylvester MA; Scott CW; Edwards PD
    Immunopharmacology; 2000 Jul; 48(2):199-212. PubMed ID: 10936517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts.
    Fiane AE; Mollnes TE; Videm V; Hovig T; Høgåsen K; Mellbye OJ; Spruce L; Moore WT; Sahu A; Lambris JD
    Xenotransplantation; 1999 Feb; 6(1):52-65. PubMed ID: 10355733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.
    Silasi-Mansat R; Zhu H; Popescu NI; Peer G; Sfyroera G; Magotti P; Ivanciu L; Lupu C; Mollnes TE; Taylor FB; Kinasewitz G; Lambris JD; Lupu F
    Blood; 2010 Aug; 116(6):1002-10. PubMed ID: 20466856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.
    Janssen BJ; Halff EF; Lambris JD; Gros P
    J Biol Chem; 2007 Oct; 282(40):29241-7. PubMed ID: 17684013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children].
    Zhang S; Li Q; Yao S
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):918-20. PubMed ID: 11702666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
    Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement depletion and persistent hemodynamic-hematologic responses in protamine-heparin reactions.
    Wakefield TW; Till GO; Lindblad B; Saenz N; Stanley JC
    J Surg Res; 1988 Sep; 45(3):320-6. PubMed ID: 3411956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass.
    Bernabei A; Gikakis N; Maione TE; Kowalska MA; Yan Z; Niewiarowski S; Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Apr; 109(4):765-71. PubMed ID: 7715225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation during cardiopulmonary bypass by heparin-protamine interaction.
    Best N; Sinosich MJ; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1984 Apr; 56(4):339-43. PubMed ID: 6608952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain injury and neuropsychological outcome after coronary artery surgery are affected by complement activation.
    Baufreton C; Allain P; Chevailler A; Etcharry-Bouyx F; Corbeau JJ; Legall D; de Brux JL
    Ann Thorac Surg; 2005 May; 79(5):1597-605. PubMed ID: 15854939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement inhibition decreases early fibrogenic events in the lung of septic baboons.
    Silasi-Mansat R; Zhu H; Georgescu C; Popescu N; Keshari RS; Peer G; Lupu C; Taylor FB; Pereira HA; Kinasewitz G; Lambris JD; Lupu F
    J Cell Mol Med; 2015 Nov; 19(11):2549-63. PubMed ID: 26337158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.